Enwei Pharmaceutical Co., Ltd. (SHE:301331)
China
· Delayed Price · Currency is CNY 28.57
+0.72 (2.59%)
At close: Mar 10, 2026
Enwei Pharmaceutical Revenue
Enwei Pharmaceutical had revenue of 187.63M CNY in the quarter ending September 30, 2025, with 8.97% growth. This brings the company's revenue in the last twelve months to 888.64M, up 14.57% year-over-year. In the year 2024, Enwei Pharmaceutical had annual revenue of 812.13M with 3.43% growth.
Revenue (ttm)
888.64M
Revenue Growth
+14.57%
P/S Ratio
3.25
Revenue / Employee
574.06K
Employees
1,548
Market Cap
2.89B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Hainan Huluwa Pharmaceutical Group | 1.06B |
| Guhan Pharmaceutical Group | 351.79M |
| Hainan Shuangcheng Pharmaceuticals | 216.15M |
| Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD | 914.65M |
| Shaanxi Kanghui Pharmaceutical | 513.23M |
| Zhejiang Shapuaisi Pharmaceutical | 475.19M |
| Ginwa Enterprise (Group) | 550.44M |
| Anhui Fengyuan Pharmaceutical | 4.15B |